kabutan

ZERIA PHARMACEUTICAL CO.,LTD., First Half Ordinary Profit Revised Upward by 42%, Adds to Record High Profit Forecast, Full Year also Increased

Tue Nov 5, 2024 11:00 am JST Revision

4559 ZERIA PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Guidance Update Report

ZERIA PHARMACEUTICAL CO.,LTD. <4559> [TSE-P] announced a performance revision in the morning on November 5th (11:00). The consolidated ordinary profit for the cumulative second quarter of the fiscal year ending March 2025 (April to September) has been revised upward by 41.8%, from the previous forecast of 5.6 billion yen to 7.94 billion yen (compared to 5.49 billion yen in the same period of the previous year), increasing the growth rate from 1.9% to 44.5%, further surpassing the previous forecast of record-high profits for three consecutive terms.

Following the strong performance in the first half, the full-year consolidated ordinary profit has been revised upward by 10.0%, from the previous forecast of 10 billion yen to 11 billion yen (compared to 8.51 billion yen in the previous period), increasing the growth rate from 17.5% to 29.2%, further surpassing the previous forecast of record-high profits for three consecutive terms.

Kabutan News

Guidance Update

First Half Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 Prev 41,000 5,600 5,600 4,300 97.6 23 May 9, 2024 J-GAAP
Apr - Sep, 2024 New 42,420 6,450 7,940 6,060 137.5 23 Nov 5, 2024 J-GAAP
Revision Rate +3.5% +15.2% +41.8% +40.9% +40.9%

Full Year Update

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2025 Prev 83,000 10,000 10,000 7,800 177.0 46 May 9, 2024 J-GAAP
Mar, 2025 New 86,000 11,000 11,000 8,500 192.8 46 Nov 5, 2024 J-GAAP
Revision Rate +3.6% +10.0% +10.0% +9.0% +9.0%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2023 36,678 5,327 5,495 5,396 122.4 22 Nov 1, 2023 J-GAAP
Apr - Sep, 2024 Guidance 42,420 6,450 7,940 6,060 137.5 23 Nov 5, 2024 J-GAAP
YoY +15.7% +21.1% +44.5% +12.3% +12.3%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2023 68,383 9,014 7,579 6,195 140.3 40 May 11, 2023 J-GAAP
Mar, 2024 75,725 9,621 8,513 7,731 175.4 44 May 9, 2024 J-GAAP
Mar, 2025 Guidance 86,000 11,000 11,000 8,500 192.8 46 Nov 5, 2024 J-GAAP
YoY +13.6% +14.3% +29.2% +9.9% +9.9%

Related Articles